RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

BOSTON, March 17, 2023 /PRNewswire/ — RVAC Medicines (US), Inc., a messenger RNA (mRNA) technology company with its global headquarters in Singapore, today announced the collaboration under a Sponsored Research Agreement with the University of Pennsylvania (“Penn”) focused on the…

Click here to view original post